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ABSTRACT
Mammalian RNAi machinery facilitating transcrip-
tional gene silencing (TGS) is the RNA-induced tran-
scriptional gene silencing-like (RITS-like) complex,
comprising of Argonaute (Ago) and small interfering
RNA (siRNA) components. We have previously de-
monstrated promoter-targeted siRNA induce TGS
in human immunodeficiency virus type-1 (HIV-1)
and simian immunodeficiency virus (SIV), which pro-
foundly suppresses retrovirus replication via het-
erochromatin formation and histone methylation.
Here, we examine subcellular co-localization of
Ago proteins with promoter-targeted siRNAs
during TGS of SIV and HIV-1 infection. Analysis of
retrovirus-infected cells revealed Ago1 co-localized
with siRNA in the nucleus, while Ago2 co-localized
with siRNA in the inner nuclear envelope.
Mismatched and scrambled siRNAs were observed
in the cytoplasm, indicating sequence specificity.
This is the first report directly visualizing nuclear
compartment distribution of Ago-associated siRNA
and further reveals a novel nuclear trafficking mech-
anism for RITS-like components involving the actin
cytoskeleton. These results establish a model for
elucidating mammalian TGS and suggest a funda-
mental mechanism underlying nuclear delivery of
RITS-like components.
INTRODUCTION
Argonaute proteins and small RNA duplexes are the
primary components of effector complexes regulating
transcriptional gene silencing (TGS) and post-
transcriptional gene silencing (PTGS). Ago1 and
sequence-speciﬁc siRNA are both essential components
of the RNA-induced transcriptional silencing-like (RITS-
like) complex, which directs siRNA-mediated TGS in
mammalian cells (1,2). Ago1 also associates with RNA
polymerase II (RNAPII) during siRNA-mediated TGS
in humans (1). Both Ago1 and Ago2 can be found in
the nucleus of human cells (3). We have previously
shown sustained suppression of SIV and HIV-1 infections
by siRNA-mediated TGS (4–7). This process is associated
with modiﬁcation of histone tails, recruitment of histone
deacetylase 1 (HDAC1) and alteration of the chromatin
structure within the retroviral LTR. The mechanism of
siRNA-induced TGS is not well understood, particularly
in mammalian cells, and there has been no direct visual-
ization of RITS-like complex components in the nucleus.
For the RITS-like complex to function at the site of
TGS, transport of the components from the cytoplasm
into the nucleus is required. Actin is the major cytoskel-
eton component in the cytoplasm and among other
cellular processes plays an important role in intracellular
transport. Recent evidence has shown nuclear actin,
actin-binding proteins (Abps) and actin-related proteins
(Arps) are functionally important in the nucleus (8),
with actin being required for transcription by RNAPII
(9). Actin, Abps and Arps also functionally contribute
to chromatin modiﬁcations. A link between actin and its
related or binding proteins and siRNA-mediated TGS has
not been previously shown.
Our study aimed to identify the subcellular localization
of critical RITS-like complex components during
siRNA-mediated TGS of SIV and HIV-1 infections, by
examining confocal scanning immunoﬂuorescent micros-
copy images of cells co-transfected with Ago1 or Ago2
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promoter-targeted siRNAs primarily co-localized with
Ago1 in the nucleus of retrovirus-infected cells, while
Ago2 was unexpectedly found to co-localize with
promoter-targeted siRNAs primarily in the nuclear
envelope of retrovirus-infected cells. We proceeded to in-
vestigate the mechanism trafﬁcking our speciﬁc siRNAs to
subcellular compartments during TGS of both retro-
viruses and revealed a novel association between F-actin
and the nuclear compartment (comprised of both the
nucleus and nuclear envelope) of retrovirus-infected cells
during TGS. Furthermore, inhibition of actin ﬁlament
polymerization by cytochalis in D reversed both F-actin
and siRNA association with the nuclear compartment,
which instead were observed in the cytoplasm of
retrovirus-infected cells. Our ﬁndings show a distinct dis-
tribution of argonaute proteins in the nuclear compart-
ment of retrovirus-infected cells during TGS and link
the cytoskeleton with nuclear delivery of RITS-like
complex components.
MATERIALS AND METHODS
Plasmid constructs and siRNAs
Expression plasmids encoding FLAG epitope-tagged
human Ago1 (NM_012199) and Ago2 (NM_012154)
were generated by cloning Ago1 or Ago2 into the pME-
FLAG vector, which was kindly provided by Takaomi
Ishida (10), using unique XhoI and SpeI restriction
enzyme sites. SIV promoter-targeted siRNAs: si2A (50-C
CGCAAGAGGCCTTCTTA-30) (4) and si2A-scrambled
(50-TAAAGCCTCAAACCCCGGTGT-30) and SIV
Gag-targeted siRNA: siGag (50-GGATGTACAGACAA
CAGAA-30) (4) were labeled on the 30 end of the sense
and antisense strands with AlexaFluor555. HIV-1
promoter-targeted siRNAs: siPromA (50-GGGACTTTC
CGCTGGGGACTT-30) (5), siPromA-M2 (50-GGGACT
TTAAGCTGGGGACTT-30) and siPromA-scrambled
(50-AAC-AGGCACACGTCCCAGCGT-30) were labeled
on the 30 end of the antisense strand with AlexaFluor555
(Invitrogen). All AlexaFluor555-labeled siRNAs were
85–90% pure as determined by mass spectrometry
analysis.
Cell culture
Media and reagents for cell culture were purchased from
Gibco. MAGIC-5 and HeLa T4+ cells were grown in
Dulbecco’s modiﬁed Eagle’s medium (DMEM) containing
10% fetal calf serum, 5 U/ml penicillin and 50mg/ml
streptomycin (supplemented DMEM) and incubated at
37 C in a humidiﬁed incubator with 5% CO2.
Antibodies and ﬂuorescent probes
Mouse monoclonal antibody against FLAG tagged
epitope was used at 1:1000 dilution (Sigma, clone-M2
F1804). Rabbit monoclonal antibody directed against
Lamin B was used at 1:500 dilution (Abcam). Normal
mouse serum and normal rabbit serum antibody controls
were used at 1:1000 and 1:500 dilutions, respectively
(Invitrogen). AlexaFluor647-conjugated goat anti-mouse
secondary antibody (Invitrogen) and AlexaFluor488-
conjugated goat anti-rabbit secondary antibody
(Invitrogen) were used at 1:200 dilution. AlexaFlour647-
conjugated Phalloidin (AF647-Phalloidin) was used at
1:1000 dilution (Invitrogen). All antibody dilutions were
made in a 10% normal goat serum (Invitrogen) and PBS
diluent. The nuclear counterstain 40,6-diamidino-2-
phenylindole (DAPI) (Invitrogen) was used at 1:1000
dilution in PBS.
Retrovirus infections
For experiments using SIV-infected cells, 5 10
5
MAGIC-5 cells seeded into SlideFlasks (Nunc) in supple-
mented DMEM and following incubation for 16h at 37 C
in a humidiﬁed incubator with 5% CO2 cells were
inoculated with 1.5 10
7 RNA copies of SIVmac251.
Cells were infected with SIV for 24h prior to RNAi
studies. In experiments using HIV-1SF162 infected cells,
HIV-1SF162 was expanded using HUT78 cells, then HeLa
T4+ cells were inoculated with 1 10
4 RNA copies and
incubated for 9 days. Following this time, 5 10
5 infected
HeLa T4+ cells were seeded into SlideFlasks in supple-
mented DMEM and following incubation for 16h at
37 C in a humidiﬁed incubator with 5% CO2 were used
in RNAi studies. The HIV-1LAV strain used was from a
stably infected HeLa cell line, where greater than 90% of
cells express the HIV-1 envelope protein, gp120 (11). Cells
(5 10
5) were seeded into SlideFlasks in supplemented
DMEM and following incubation for 16h at 37 Ci na
humidiﬁed incubator with 5% CO2 cells were used for
RNAi studies.
RNA interference studies
Cells were transiently co-transfected with the expression
plasmids and siRNAs described above using
Lipofectamine2000 (Invitrogen) as per the manufacturer’s
instructions. Brieﬂy, 5 10
5 cells in supplemented DMEM
were seeded into SlideFlasks (Nunc) and incubated for
16h at 37 C in a humidiﬁed incubator with 5% CO2.
Cells were co-transfected with 1mg Ago1, Ago2 or
empty vector plasmids and 0.64 nL siRNA using
Lipofectamine2000 in OptiMEM medium (Invitrogen).
Supplemented DMEM was added 4h post-transfection
and cells were processed 24h later for immunoﬂuores-
cence staining and supernatants were harvested to perform
the reverse transcriptase (RT) assay measuring virus
replication.
Drug treatment with cytochalisin D
Directly preceding co-transfection with FLAG-tagged
constructs and siRNAs, mock-, SIV and HIV-1 infected
cells were pre-treated for 1h with cytochalisin D (cytD)
(Sigma) at 1mg/ml in 0.1% dimethyl sulfoxide (DMSO)/
PBS. Parallel untreated cultures were exposed to 0.1%
DMSO. Directly following the transfection process, cytD
(1mg/ml) was added to cells in OptiMEM medium.
Supplemented DMEM was added 4h post-transfection
with 1mg/ml cytD and cells were processed 24h later for
immunoﬂuorescence staining.
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Immunoﬂuorescence microscopy was performed with
MAGIC-5 and HeLa cells grown on SlideFlasks (Nunc).
The cells were transiently co-transfected with Ago1 or
Ago2 and promoter-targeted or control siRNAs as
described above. After 24h cells were washed in PBS
and ﬁxed in 4% formaldehyde (Sigma) for 10min at
RT. Cells were washed again in PBS and permeabilized
with 0.3% Triton X-100 (Sigma) for 10min at RT. To
reduce non-speciﬁc binding cells were blocked in 10%
normal goat serum for 30min at 37 C in a humidiﬁed
chamber and washed in PBS. All subsequent incubation
steps were performed at 37 C in a humidiﬁed chamber.
Cells were incubated for 1h with primary antibodies
speciﬁc for the FLAG-tag epitope, Lamin B or in subse-
quent experiments AF647-Phalloidin, washed thrice in
PBS and incubated for 30min with appropriate secondary
antibodies. Cells were washed thrice in PBS and incubated
with DAPI for 10min at RT. Slides were mounted with
coverslips and Fluromount G (Electron Microscopy
Services). Confocal images of ﬂuorescently labeled cells
were acquired with a Leica inverted confocal laser scann-
ing microscope (Leica TCS SP2) using a high-resolution
Leica 63 /1.4NA Plan Apo oil immersion objective and a
pinhole aperture setting of 1 Airy unit. The microscope
was equipped with Ar and HeNe laser lines 488nm detect-
ing AlexaFluor488, 543nm to detect AlexaFluor555 and
633nm to detect AlexaFluor647 and UV diode for 405nm
DAPI detection. Due to the broad emission spectra of
these dyes, the ﬂuorescent signals were collected only
from peak regions and acquired sequentially. Images
(8 bit) were acquired at scan speed (8s per 1024 1024
pixels) to minimize the noise, with approximately
15 optical plane slices at 0.2mm spacing in the z-axis.
Image processing and generation of Pearson’s coefﬁcient
correlation (PCC) values were performed using ImageJ
software, Version 1.42q (National Institutes of Health,
USA) (12), by ﬁrst subtracting the background and then
applying the Co-localization Analysis Plugin on the total
image area, as described by (13). At least ﬁve PCC values
were generated for each experimental treatment, from at
least ﬁve randomly selected ﬁelds. Each ﬁeld of view con-
tained up to 40 cells (magniﬁcation 63 ). Results were
obtained from three independent experiments and data
are shown from a representative experiment.
RT assay
Productive viral infection was quantiﬁed by RT activity in
culture supernatants using the method previously
described (14).
Cytoplasmic and nuclear protein extraction
HeLa cells were infected with HIV-1SF162 and transfected
with FLAG-tagged Ago1 and promoter-targeted siPromA
not labeled with AlexaFluor dye, as described above. Two
days following transfection cells were washed with ice cold
PBS and harvested using a cell scraper. The nuclear ex-
traction protocol used has been adapted to meet PC3 la-
boratory requirements (15). Cells were washed in
hypotonic buffer (10mM Tris–HCl, pH 8.0, 0.32M
sucrose, 20mM MgCl2, 0.1mM EDTA, 10mM DTT
and complete ultra EDTA-free protease inhibitors
(Roche) (15). Following centrifugation cells were washed
and lysed in hypotonic buffer during a 45min incubation
on ice. Nuclei were isolated and puriﬁed by passing lysate
through a p200 pipette tip 20 times, followed by passage
through a p20 tip 20 times. Nuclei were sedimented by
centrifugation at 3000g at 4 C for 5min, the supernatant
containing cytoplasmic fraction was collected and the
nuclear pellet was resuspended in hypotonic buffer con-
taining 0.5M sucrose and sedimented by centrifugation at
3000g at 4 C for 5min. Nuclear proteins were isolated in
extraction buffer (400mM NaCl, 20mM HEPES, pH 7.9,
25% glycerol, 1.5mM MgCl2, 0.4mM EDTA, 1mM DTT
and complete ultra EDTA-free protease inhibitors) for
30min at 4 C (15). Insoluble nuclear residues were sedi-
mented at 3000g at 4 C for 10min and the supernatant
was collected. Collected cytoplasmic and nuclear fractions
were applied for immunoprecipitation (IP).
IP, SDS–PAGE and western blot analysis
Protein fractions were diluted in two volumes of PBS to
decrease the salt concentration and samples were
incubated with anti-FLAG M2 agarose afﬁnity gel over-
night at 4 C with rotation. Immunoprecipitates were
washed four times with PBS supplemented with complete
ultra EDTA-free protease inhibitors. Loading buffer with-
out reducing agent (Invitrogen) was added and samples
were boiled for 5min, centrifuged and supernatant was
loaded onto an Invitrogen NuPage 4–12% Bis-Tris gel
and separated for 35min at 200V. Separated proteins
were transferred onto a PVDF membrane for 90min at
30V, blocked in 2.5% skimmed milk/TBS and
immunoblotted with mouse anti-b-actin (1:2500, Sigma,
A5441 clone AC-15) or rabbit anti-Argonaute 1/2/3/4
polyclonal antibody (1:500, Thermo Scientiﬁc, PA1-
41178) at room temperature for 1h or mouse anti-
FLAG M2 (1:3000, Sigma, clone M2 F1804) (16) at
37 C for 1h. All dilutions were prepared in 2.5%
skimmed milk/TBS. Prior to addition of secondary sheep
anti-mouse HRP antibody (1:3000) immunoblots were
washed in TBS/0.1% Triton X-100. Immunoblots were
developed using Immuno-Star HRP chemiluminescent
reagents as per manufacturer’s instructions (Bio-Rad)
and visualized using Quantity One chemiluminescence
software.
Statistical analysis
RT values are given as mean and SEM and were tested for
signiﬁcance using a paired, two-tailed t-test. PCC values
are given as the mean and SEM and statistical compari-
sons of PCC correlations were performed using the
non-parametric Mann–Whitney test, since the data are
unpaired, and with the low sample number (n=5 or 6)
no assumption can be made regarding normal Gaussian
distribution. A P-value <0.05 was considered statistically
signiﬁcant. All analyses were performed using Graphpad
Prism Version 5.0a (Graphpad Software, San Diego, CA,
USA).
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si2A targeting the promoter region suppresses SIV
replication
Based on our previous report of si2A potently suppressing
SIV replication through targeted promoter binding, we
used this siRNA and a scrambled siRNA control
AlexaFluor555-labeled at the 30-ends of both antisense
and sense strands (Figure 1A), with FLAG-tagged Ago1
or Ago2 constructs to examine their subcellular localiza-
tion during RNA-induced TGS of SIVmac251 infection.
Based on known argonaute sequences and domains,
comprising of the N-terminus, a Piwi-Argonaute-Zwille
(PAZ) domain, a MID domain and C-terminal PIWI
domain, along with recent crystallography studies report-
ing the 50 phosphate of small RNAs bind argonaute
proteins via a binding pocket in the MID domain (17),
we predicted that fusing a FLAG-tag to the N-terminal
of our argonaute constructs would not interfere with this
interaction. To conﬁrm this, we assessed the ﬂuorophore-
labeled siRNAs ability to suppress SIV replication in the
presence of N-terminal FLAG-tagged Ago1 and observed
greater than 7-fold suppression on Day 6 post-infection
when compared to scrambled siRNA (si2A-Sc-AF555) or
mock controls as measured by reverse transcriptase (RT)
assay (Figure 1B). We also conﬁrmed the functionality of
the FLAG-tagged Ago1 compared to endogenous Ago
proteins by performing RT assays on SIV-infected cells
transfected with the labeled siRNAs alone. We found
that cultures transfected with FLAG-tagged Ago1 and
si2A-AF555 had a signiﬁcant twofold greater decrease in
RT activity (P=0.0005) compared to cells transfected
with si2A-AF555 alone, indicting the transfected FLAG-
tagged Ago construct expresses functional protein that
contributes substantially to the observed viral suppression
in addition to that mediated by endogenous Ago proteins
alone (Figure 1B). This conﬁrmed our previous study
showing unlabeled si2A mediates SIV suppression via
TGS (4) and demonstrate the addition of a ﬂuorophore
to the siRNA 30-end (si2A-AF555) did not perturb its
ability to suppress SIV replication, nor did the
N-terminal FLAG-tag interfere with this process.
Ago1 co-localizes with si2A in the nucleus of
SIV-infected cells
Having established the ﬂuorophore-labeled siRNAs and
FLAG-tagged Ago constructs were functional, we pro-
ceeded to investigate the subcellular compartments in
which RITS-like components localize during TGS. We
used MAGIC-5 cells, which express the preferred
SIVmac251 co-receptor, CCR5 (along with CD4 and
CXCR4), and infected with SIV or mock-infected for
24h, then co-transfected with FLAG-tagged Ago1 or
empty vector and si2A-AF555 or si2A-Sc-AF555 for a
further 24h. Following immunoﬂuorescent staining, the
cells were analyzed by confocal laser scanning microscopy.
We observed si2A-AF555 and Ago1 localized predomin-
antly to the cytoplasm of mock-infected cells, with some
co-localization (Figure 2A). In stark contrast, si2A-AF555
and Ago1 were observed to co-localize in the nuclear com-
partment of SIV-infected cells (Figure 2B). Mock- and
SIV-infected cells co-transfected with si2A-Sc-AF555
(Figure 2C) and Ago1 or empty vector controls showed
only cytoplasmic staining and some low level
co-localization. As expected the PTGS inducing Gag-
speciﬁc siRNA, siGag-AF555, was observed in the cyto-
plasm, but not the nucleus, of both mock- and
SIV-infected cells (Supplementary Figure S1A–B). The
observations of Ago1:si2A and Ago1:siGag co-localizing,
respectively, in the nucleus and cytoplasm of SIV-infected
cells is consistent with TGS occurring in the nucleus and
PTGS in the cytoplasm. Consistent with a previous study,
we also observed larger siRNA aggregates compared to
Ago protein staining patterns (18). No nuclear envelope
co-localization with LaminB was observed for Ago1 or
siRNAs in mock- or SIV-infected cultures. Image
analysis revealed a signiﬁcant co-localization between
si2A-AF555 or Ago1 and the nucleus of SIV-infected
Figure 1. siRNA targeting the promoter region of SIVmac251 inhibits viral replication in MAGIC-5 cells. (A)5 0LTR sequence of SIVmac251
targeted by siRNAs; si2A and si2A-Scrambled control (si2A-Sc) are shown under the green bar at  164bp. The NF-kB binding motif is shown
above the blue bar at  49bp. Nucleotide numbering is relative to the transcription start site. (B) The viral reverse transcriptase activity in culture
supernatant, measured 6 days after virus infection of MAGIC-5 cells and transfection with FLAG-tagged Ago1 or without FLAG-tagged Ago1- and
SIV-speciﬁc siRNAs; si2A and siGag, and speciﬁcity control, scrambled siRNA (si2A-Sc) or Lipofectamine2000 alone (mock) *P 0.02,
**P=0.002, *** P=0.008; NS, not signiﬁcant; RT, reverse transcriptase.
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(PCC: 0.52±0.05 and 0.31±0.03, respectively)
(mean±SEM) compared to mock-infected cells
(0.15±0.02 and 0.11±0.02, respectively) (both
P=0.008) and all other comparator cultures (Figure
2D). Although SIV-infected cells co-transfected with
si2A-Sc-AF555 and Ago1 showed slightly increased PCC
for nuclear co-localization (0.27±0.03 and 0.19±0.02,
respectively), the mean values were still signiﬁcantly lower
compared to SIV-infected cells co-transfected with
si2A-AF555 and Ago1 (P=0.008). Importantly, a signiﬁ-
cant degree of co-localization was reported between
si2A-AF555 and Ago1 in SIV-infected cells (0.36±0.02)
compared to mock-infected cells (0.12±0.04)
(P=0.002). There were no signiﬁcant correlations for
siRNAs and Ago1 co-localization, nuclear localization
(Figure 2D) or nuclear envelope localization (data not
shown) observed in any other control cultures. These
results clearly demonstrate Ago1 and the
promoter-targeted si2A preferentially co-localize at the
site of TGS in SIV-infected cells.
Ago2 co-localizes with si2A in the nuclear envelope
of SIV-infected cells
To elucidate the subcellular localization of Ago2 during
TGS of SIV, we co-transfected MAGIC-5 cells with Ago2
and the same panel of ﬂuorophore-labeled siRNAs as in
the previous experiments. Confocal images revealed si2A-
AF555 and Ago2 localized to the cytoplasm of mock-
infected cells, with some co-localization (Figure 3A).
Intriguingly, SIV-infected cells co-transfected with Ago2
and si2A-AF555 displayed distinct nuclear envelope
(LaminB) co-localization (Figure 3B), whereas mock- or
SIV-infected cells co-transfected with si2A-Sc-AF555
(Figure 3C) or siGag-AF555 and Ago2 or empty vector
controls all showed cytoplasmic staining only, with some
co-localization (data not shown). Again as expected,
siGag-AF555 and Ago2 were observed in the cytoplasm
of mock- and SIV-infected cells, with some co-localization
(Supplementary Figure S1C–D). This observation is
consistent with sequence-speciﬁc siRNA (in our case
siGag) and Ago2 being key components of RISC
Figure 2. Immunoﬂuorescent analysis of SIV promoter-targeted siRNA and Ago1 in MAGIC-5 cells. (A) Mock-infected cells co-transfected with
Ago1 and si2A. (B) SIV-infected cells co-transfected with Ago1 and si2A. (C) SIV-infected cells co-transfected with Ago1 and scrambled siRNA.
siRNAs (si2A and si2A-Sc) labeled with AF555 show red ﬂuorescence, FLAG-tagged epitope representing Ago1 is labeled with AF647
(pseudocolored magenta), Lamin B labeled with AF488 (green ﬂuorescence) indicates nuclear envelope and DAPI nuclear stain is pseudocolored
blue. Arrows indicate nuclear localization in SIV-infected cells. Magniﬁcation 63 , scale bars indicate 5mm. Images are representative of three
experiments. (D) Pearson’s correlation coefﬁcient values are shown for siRNA and DAPI (left panel), Ago1 and DAPI (middle panel) and siRNA
and Ago1 (right panel). **P=<0.008.
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cells. The PCC values conﬁrmed a signiﬁcant
co-localization between the nuclear envelope of
SIV-infected cells co-transfected with si2A-AF555 and
Ago2 (0.29±0.02 and 0.30±0.02, respectively)
compared to mock-infected cells (0.16±0.01 and
0.13±0.01, respectively) (P=0.02 and 0.008, respective-
ly) and all other cultures (Figure 3D). There was also a
low degree of correlation between staining for either
si2A-AF555 or Ago2 with the nucleus of SIV-infected
cells (0.23±0.02 and 0.19±0.02, respectively)
compared to mock-infected cells (0.14±0.01 and
0.13±0.01, respectively) (both P=0.03). Importantly,
si2A-AF555 and Ago2 showed a signiﬁcant degree of
co-localization in infected cells (0.27±0.02) compared
to mock-infected cells (0.15±0.02) (P=0.02). These
data demonstrate that Ago2 and the promoter-targeted
si2A, but not the control siRNAs, co-localize predomin-
ately within the nuclear envelope of SIV-infected cells.
siPromA suppresses HIV-1 virus replication
Based on our ﬁndings in SIV infection, we hypothesized
that promoter-targeted siRNA and Ago1 and 2 proteins
may co-localize similarly during RNA-induced TGS of
HIV-1 infection. To test this hypothesis, we utilized two
different HIV-1 subtype B strains, SF162 (a T cell line
adapted CCR5-tropic virus) and LAV (a CXCR4-tropic
virus) to assess whether the ﬂuorophore-labeled siRNA
were functional in suppressing HIV-1 subtype B virus in-
fection. Our previous studies have described the siPromA
sequence as a potent siRNA transcriptional suppressor of
HIV-1, by interacting with the tandem NF-kB binding
sites in the 50LTR (5). We labeled this siRNA
(siPromA), a two base pair mismatch siRNA (siPromA-
M2) and a scrambled siRNA control (siPromA-Sc) with
AF555 only on the antisense strand 30 end and assessed
whether virus suppression was disrupted by the addition
of a 30 ﬂuorophore in the presence of FLAG-tagged Ago1
Figure 3. Immunoﬂuorescent analysis of SIV promoter-targeted siRNA and Ago2 in MAGIC-5 cells. (A) Mock-infected cells co-transfected
with Ago2 and si2A. (B) SIV-infected cells co-transfected with Ago2 and si2A. (C) SIV-infected cells co-transfected with Ago2 and scrambled
siRNA. siRNAs (si2A and si2A-Sc) labeled with AF555 show red ﬂuorescence, FLAG-tagged epitope representing Ago2 is labeled with
AF647 (pseudocolored magenta), Lamin B labeled with AF488 (green ﬂuorescence) indicates nuclear envelope and DAPI nuclear stain is
pseudocolored blue. Arrows indicate nuclear localization in SIV-infected cells. Magniﬁcation x63, scale bars indicate 5mm. Images are representative
of three experiments. (D) Pearson’s correlation coefﬁcient values are shown for siRNA and DAPI (upper left panel), Ago2 and DAPI (upper middle
panel), siRNA and Ago2 (upper right panel), siRNA and LaminB (lower left panel) and Ago2 and LaminB (lower right panel). *P 0.03.
**P 0.008.
1584 Nucleic Acids Research, 2012,Vol.40, No. 4(Figure 4A). We observed >50-fold reduction in replica-
tion of HIV-1SF162 on Day 5 post-transfection when
compared to scrambled and mismatched siRNAs or
mock controls as measured by RT assay (Figure 4B). As
above we reconﬁrmed the functionality of the FLAG-
tagged Ago1 as well as FLAG-tagged Ago2 compared
to endogenous Ago proteins by performing RT assays
on HIV-1SF162 infected cells transfected with HIV-1
speciﬁc labeled siRNAs alone. Again, we found that cul-
tures transfected with FLAG-tagged Ago1 and siPromA-
AF555 or FLAG-tagged Ago2 and siPromA-AF555 had a
signiﬁcant 1.9-fold and 2.2-fold greater decrease in RT
activity (P=0.03 and 0.04, respectively) compared
to cells transfected with siPromAA-AF555 alone, indict-
ing the expression of FLAG-tagged Ago proteins is func-
tional and contributes to a greater viral suppression than
endogenous Ago proteins alone (Figure 4B). We also
showed greater than 2-fold reduction in HIV-1LAV repli-
cation on day 5 post-transfection with both labeled
siRNAs and FLAG-tagged Ago1, compared to the
scrambled and mismatched siRNAs or mock controls
(Supplementary Figure S2A). These ﬁndings conﬁrm
our previous data showing unlabeled siPromA mediates
HIV-1 suppression via TGS (5) and reiterates our SIV
data by demonstrating the addition of a ﬂuorophore
to the 30 siRNA end does not disrupt any interaction
with the HIV-1 promoter region. This process appears to
be highly speciﬁc as there was no impact on production of
either virus strain mediated by the variant M2 siRNA,
which only varies from the promA siRNA sequence by
2bp, or the scrambled siRNA and conﬁrms published spe-
ciﬁcity data using these siRNAs (16). These results show
the antisense ﬂuorophore-labeled siPromA successfully
and speciﬁcally suppressed HIV-1 replication of both
subtype B strains, SF162 and LAV.
Ago1 co-localizes with the antisense strand of siPromA
in the nucleus of HIV-1 infected cells
To elucidate the subcellular localization of Ago1 and the
promoter-targeted siPromA during TGS of HIV-1
infection, we used HIV-1SF162 or HIV-1LAV infected and
mock-infected HeLa T4+ cells co-transfected with
FLAG-tagged Ago1 or empty vector and antisense
strand AF555-labeled siPromA, along with siPromA-M2
or siPromA-Sc as controls. Following immunoﬂuorescent
staining, cells were analyzed by confocal laser scanning
microscopy and both HIV-1 subtype B strain-infected
cells displayed a similar Ago1:siRNA co-localization
pattern to that observed in SIV-infected cells. Ago1 and
antisense siPromA-AF555 localized to the cytoplasmic
compartment of mock-infected cells, with some
co-localization (Figure 5A, Supplementary Figure S2B),
while Ago1 and antisense siPromA-AF555 predominantly
co-localized in the nucleus of both HIV-1SF162 (Figure 5B)
and HIV-1LAV infected cells (Supplementary Figure S2C).
In contrast, mock-, HIV-1SF162 (Figure 5C) and HIV-1LAV
infected cells (Supplementary Figure S2D) co-transfected
with siPromA-Sc-AF555 and Ago1 (or empty vector, data
not shown) displayed cytoplasmic staining and some
co-localization. Similarly, mock- and all HIV-1 infected
cells co-transfected with siPromA-M2-AF555 and Ago1
(or empty vector, data not shown) also revealed only cyto-
plasmic staining with some co-localization. Our observa-
tions of Ago1 and antisense siPromA predominantly
co-localizing in the nucleus of HIV-1 infected cells are
consistent with the nuclear TGS pathway and support
our ﬁndings in SIV-infected cultures. PCC values
generated by confocal image analysis showed a signiﬁcant
correlation between antisense siPromA-AF555 or Ago1 in
the nucleus of HIV-1SF162 infected cells (0.36±0.02 and
0.40±0.02, respectively) compared to mock-infected cells
(0.16±0.02 and 0.15±0.02, respectively) (both
P=0.002) and all other cultures (Figure 5D), with a
similar correlation reported in the nucleus of HIV-1LAV
infected cells (Supplementary Figure S2E). No signiﬁcant
correlations for nuclear co-localization were reported in
any mock-infected cells or HIV-1 infected cells co-
transfected with siRNA controls; siPromA-Sc-AF555
and siPromA-M2-AF555, or empty vector. Once again,
the promoter-targeted siRNA, siPromA and Ago1
Figure 4. siRNA targeting the promoter region of HIV-1 inhibits viral replication in HeLa T4+cells. (A)5 0LTR sequence of HIVSF162 and HIVLAV
targeted by siRNAs; siPromA, siPromA-Sc and siPromA-M2 control are highlighted. Nucleotide numbering is relative to the transcription start site.
(B) Viral reverse transcriptase activity in culture supernatant, measured 5 days after infection of HeLa T4+cells and transfection with siRNA alone,
FLAG-tagged Ago1 or Ago2 and HIV speciﬁc siRNA; siPromA and speciﬁcity controls; siPromA-Sc and siPromA-M2 or Lipofectamine2000 alone
(mock) *P=< 0.02, **P=0.002, ***P=0.008.
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HIV-1SF162 infected cells (0.40±0.02) compared to
mock-infected cells (0.18±0.02) (P=0.002). These
results clearly demonstrate that Ago1 co-localizes with
the antisense strand of promoter-targeted siPromA in
the nucleus of cells infected with either HIV-1SF162 or
HIV-1LAV strains.
Ago2 co-localizes with the antisense strand of siPromA
in the nuclear envelope of HIV-1 infected cells
We also examined the subcellular compartmentalization
of Ago2 and siPromA during TGS of HIV-1 infection,
using HIV-1SF162 or HIV-1LAV infected and mock-infected
HeLa T4+cells, co-transfected with Ago2 or empty vector
and our panel of antisense strand ﬂuorophore-labeled
siRNAs. Confocal images again revealed cells infected
with either HIV-1 subtype B strain showed the same
intriguing Ago2:siRNA co-localization pattern as seen
in SIV-infected cells. While mock-infected cultures dis-
played Ago2 and siPromA-AF555 localized to the
cytoplasmic compartment, with some co-localization
observed (Figure 6A), HIV-1SF162 (Figure 6B) and
HIV-1LAV infected cells (Supplementary Figure S3B)
showed distinct nuclear envelope membrane
co-localization of Ago2 and antisense strand
siPromA-AF555. Mock- or HIV-1SF162 (Figure 6C) and
HIV-1LAV infected cells (Supplementary Figure S3C)
co-transfected with siPromA-Sc-AF555 and Ago2
showed predominantly cytoplasmic staining, with some
co-localization. Similarly, mock- and both HIV-1
subtype B strain infected cells co-transfected with
siPromA-M2-AF555 and Ago2 (or empty vector, data
not shown) also revealed predominantly cytoplasmic
staining with some co-localization. ImageJ analysis
showed a signiﬁcant correlation between siPromA or
Ago2 and nuclear envelope staining in HIV-1SF162
infected cells (0.38±0.02 and 0.40±0.03, respectively)
compared to mock-infected cells (0.11±0.02 and
0.10±0.02, respectively) (both P=0.002) and all other
cultures (Figure 6D), with a similar correlation reported in
Figure 5. Immunoﬂuorescent analysis of HIV-1 promoter-targeted siRNA and Ago1 in HeLa cells. (A) Mock-infected cells co-transfected with Ago1
and siPromA. (B) HIVSF162-infected cells co-transfected with Ago1 and siPromA. (C) HIVSF162-infected cells co-transfected with Ago1 and scrambled
siRNA. siRNAs (siPromA and siPromA-Sc) labeled with AF555 show red ﬂuorescence, FLAG-tagged epitope representing Ago1 is labeled with
AF647 (pseudocolored magenta), Lamin B labeled with AF488 (green ﬂuorescence) indicates nuclear envelope and DAPI nuclear stain is
pseudocolored blue. Arrows indicate nuclear localization in HIVSF162-infected cells. Magniﬁcation 63 , bars represent 5mm. Images are represen-
tative of three experiments. (D) Pearson’s correlation coefﬁcient values are shown for siPromA and DAPI (left panel), Ago1 and DAPI (middle
panel) and siPromA and Ago1 (right panel). **P=0.002.
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(Supplementary Figure S3D). No signiﬁcant correlations
were reported in mock-infected cells or HIV-1 infected
cells co-transfected with Ago2 or empty vector and
siRNA controls; siPromA-Sc-AF555 and
siPromA-M2-AF555. There was also no signiﬁcant correl-
ation between siPromA-AF555 staining and nuclear
staining of HIV-1 infected cells. Ago2 showed some
co-localization with the nucleus in HIV-infected cells
compared to mock-infected cells (P=0.01), although
this correlation was due to overlap between the nucleus
and the nuclear envelope and was no longer signiﬁcant
when compared to empty vector or siPromA-M2 trans-
fected controls in infected cells. These results clearly dem-
onstrate that Ago2 and the antisense strand of siPromA
co-localize predominately within the nuclear envelope of
cells infected with HIV-1SF162 or HIV-1LAV subtype B
strains.
Cytoplasmic actin ﬁlaments translocate to the nuclear
compartment of retrovirus-infected cells during TGS
The distinct subcellular co-localization patterns of Ago1
and Ago2 with our promoter-targeted siRNAs during
TGS of retroviral infections led us to investigate the mech-
anism trafﬁcking RITS-like complex components to
speciﬁc subcellular compartments. Since actin and Arps
are known to be functional in chromatin-modifying com-
plexes and play a role in intracellular transport, including
actin-mediated entry of HIV into the nucleus (22),
we hypothesized that the cytoskeleton, speciﬁcally its
major actin component, was involved in delivering
RITS-like complex components to their distinct sub-
cellular sites. We investigated this using the same infection
and co-transfection model as described in previous experi-
ments, using SIV or HIV-1SF162 infected cells that were
then co-transfected with the appropriate panels of
Figure 6. Immunoﬂuorescent analysis of HIV-1 promoter-targeted siRNA and Ago2 in HeLa cells. (A) Mock-infected cells co-transfected with Ago2
and siPromA. (B) HIVSF162-infected cells co-transfected with Ago2 and siPromA. (C) HIVSF162-infected cells co-transfected with Ago2 and scrambled
siRNA. siRNAs (siPromA and siPromA-Sc) labeled with AF555 show red ﬂuorescence, FLAG-tagged epitope representing Ago2 is labeled with
AF647 (pseudocolored magenta), Lamin B labeled with AF488 (green ﬂuorescence) indicates nuclear envelope and DAPI nuclear stain is
pseudocolored blue. Arrows indicate nuclear localization in HIVSF162-infected cells. Magniﬁcation 63 , bars represent 5mm. Images are represen-
tative of three experiments. (D) Pearson’s correlation coefﬁcient values are shown for siPromA and DAPI (upper left panel), Ago2 and DAPI (upper
middle panel), siPromA and Ago2 (upper-right panel), siPromA and LaminB (lower left panel) and Ago2 and LaminB (lower right panel). NS, not
signiﬁcant. *P=0.01, **P=0.002.
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for 24h. We then immunoﬂuorescently stained cellular
actin ﬁlaments with Phalloidin-AF647, a mushroom-
derived toxin speciﬁcally detecting actin polymers
(F-actin), but not actin monomers (G-actin) (23). Since
Phalloidin was labeled with the same ﬂuorophore as our
secondary antibody detecting FLAG-tagged Ago, we did
not stain for Ago1 in this experiment and maintained the
use of our established 4-color confocal imaging panel. We
observed mock-infected cells co-transfected with si2A-
AF555 (Supplementary Figure S4A) or siPromA-AF555
(Figure 7A) possessed normal cytoskeleton distribu-
tion, with F-actin ﬁbers localized at the cell periphery
and throughout the cytoplasm. Surprisingly, in SIV-
(Supplementary Figure S4B) and HIV-1SF162 (Figure 7B)
infected cells co-transfected with si2A-AF555 or siPromA-
AF555, respectively, there was F-actin rearrangement
and translocation of actin ﬁlaments to the nuclear com-
partment. In contrast, mock-, SIV- (Supplementary
Figure S4C) and HIV-1SF162 (Figure 7C) infected cells
co-transfected with scrambled siRNAs displayed cytoplas-
mic F-actin staining, as did mock- and retrovirus-infected
cells co-transfected with siGag-AF555 or siPromA-M2-
AF555 (data not shown). This illuminating result demon-
strates siRNA-mediated TGS of retroviruses is associated
with reorganization of the cytoskeleton, which may
be involved in nuclear transport of siRNA in the RITS-
like complex. Interestingly, while image analysis showed
an expected signiﬁcant correlation between si2A-AF555 or
siPromA-AF555 and the nucleus of SIV- (Supplementary
Figure S4D) or HIV-1SF162 (Figure 7D) infected cells
(0.51±0.05 and 0.31±0.02, respectively) compared
to mock-infected cells (0.15±0.02 and 0.16±0.02, re-
spectively) (P=0.008 and 0.002, respectively) and all
other cultures, no signiﬁcant co-localization was
reported between si2A-AF555 or siPromA-AF555 and
F-actin in the nucleus. This was despite low-level correl-
ation between F-actin and the nucleus of SIV- and
HIV-1SF162 infected cells (0.25±0.02 and 0.22±0.02, re-
spectively) compared to mock-infected cells (0.09±0.02
Figure 7. Immunoﬂuorescent analysis of HIV-1 promoter-targeted siRNA and F-actin in HeLa cells. (A) Mock-infected cells co-transfected with
Ago1 and siPromA. (B) HIV-infected cells co-transfected with Ago1 and siPromA. (C) HIV-infected cells co-transfected with Ago1 and scrambled
siRNA. siRNAs (siPromA and siPromA-Sc) labeled with AF555 show red ﬂuorescence, F-actin is labeled with phalloidin-AF647 (pseudocolored
magenta), Lamin B labeled with AF488 (green ﬂuorescence) indicates nuclear envelope and DAPI nuclear stain is pseudocolored blue. Arrows
indicate nuclear localization in HIV-infected cells. Magniﬁcation 63 , bars represent 5mm. Images are representative of three experiments. (D)
Pearson’s correlation coefﬁcient values are shown for siPromA and DAPI (upper left panel), F-actin and DAPI (upper middle panel), siPromA and
F-actin (upper right panel), siPromA and LaminB (lower-left panel) and F-actin and LaminB (lower right panel). NS, not signiﬁcant. * P=0.02,
**P=0.002.
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results indicate a lack of co-localization in the nucleus
between our promoter-targeted siRNAs and F-actin,
even though both independently showed nuclear localiza-
tion in retrovirus-infected cells. Even more interesting was
our observation of a signiﬁcant correlation between
F-actin and the inner nuclear envelope membrane of
SIV- and HIV-1SF162 infected cells co-transfected with
si2A-AF555 or siPromA-AF555, respectively
(0.35±0.05 and 0.31±0.02, respectively) compared to
mock-infected cells (0.12±0.02 and 0.09±0.01, respect-
ively) (both P=0.002). No signiﬁcant correlations for
nuclear or nuclear envelope localization were reported in
any mock-, SIV- or HIV-1 infected cells co-transfected
with scrambled siRNA controls, siGag-AF555 or
siPromA-M2-AF555. Our ﬁnding of cytoskeleton
nuclear translocation during siRNA-mediated TGS in
two retroviruses suggests actin ﬁlaments may be
involved in nuclear transport of promoter-targeted
siRNA in the RITS-like complex.
Actin ﬁlaments co-localize and biochemically associate
with Ago1 and 2 in the nuclear compartment of
HIV-1 infected cells during TGS
To determine whether F-actin and Ago1 interact spatially
we performed the same infection and co-transfection
model as described in previous experiments, using
HIV-1SF162 infected cells that were then co-transfected
with the appropriate panels of nonlabeled siRNAs and
FLAG-tagged Ago1 or 2 or empty vector for 24h. We
then immunoﬂuorescently stained cellular actin ﬁlaments
with Phalloidin-AF647 and detected FLAG-tagged Ago1
or 2 with a secondary AF555 antibody to maintain the use
of our established 4-color confocal imaging panel. We
observed mock-infected cells co-transfected with
siPromA-AF555 possessed normal cytoskeleton distribu-
tion, with F-actin ﬁbers localized at the cell periphery and
throughout the cytoplasm, and Ago1 or Ago2 also
localized to the cytoplasm (Figure 8A and Supplementary
Figure S5A, respectively). In contrast, HIVSF162 infected
cultures showed F-actin and Ago1 clearly co-localized in
the nucleus (Figure 8B), while F-actin and Ago2
co-localized to the nuclear envelope (Supplementary
Figure S5B). Cultures transfected with siPromA-Sc-
AF555 (Figure 8C and Supplementary Figure S7C)
empty vector or mock-infected all showed clear cytoplas-
mic staining of both F-actin and Ago1 or 2. PCC values
indicated a signiﬁcant correlation between F-actin and
Ago1 (Figure 8D) and F-actin and Ago2 (Supplementary
Figure S5D) in infected cultures compared to mock-
infected cultures transfected with siPromA-AF555
(0.29±0.06 and 0.25±0.04, respectively) (both
P=0.002). Interestingly, F-actin staining showed signiﬁ-
cant correlation with LaminB staining in both Ago1 or
Ago2 transfected and siPromA-AF555 transfected cul-
tures that were infected with HIV-1 compared to
mock-infected cultures (0.25±0.02 and 0.24±0.02, re-
spectively) (both P=0.002). No signiﬁcant correlations
for nuclear or nuclear envelope localization were reported
in any mock- or HIV-1 infected cells co-transfected with
scrambled siRNA controls, siPromA-M2-AF555 or
empty vector.
To deﬁnitively conﬁrm the co-localization observed
between F-actin and Ago1 occurs via a protein–protein
association, we performed IP analysis of HIV-1SF162
infected cultures transfected with FLAG-tagged Ago1 or
empty vector and unlabeled siPromA. We employed
FLAG-M2 agarose afﬁnity gel to pull-down FLAG-
tagged Ago1 and associated proteins. Following immuno-
blotting using a b-actin speciﬁc antibody, we observed a
42kDa band representative of b-actin in nuclear and cyto-
plasmic fractions of the IP samples of cultures transfected
with FLAG-tagged Ago1, but not in cultures transfected
with empty vector (Figure 8E, upper panel). We also
immunoblotted for FLAG-tag using a FLAG-M2
speciﬁc antibody and showed FLAG-tag presence
( 90kDa band) in FLAG-tagged Ago1 transfected cul-
tures (Figure 8E, lower panel). Further, we immuno-
blotted for Ago protein using an Ago-speciﬁc antibody
and showed Ago protein ( 90kDa band) was present in
all input samples, but only in the nuclear IP fraction of
Ago1-transfected cultures (Figure 8E middle panel). Our
ﬁndings clearly demonstrate both co-localization of
F-actin and FLAG-tagged Ago1 or 2 and a protein inter-
action between F-actin and FLAG-tagged Ago1 during
siRNA-mediated TGS, suggesting that actin ﬁlaments
may be involved in nuclear transport of Ago1 in a
RITS-like complex.
Actin ﬁlament depolymerization by cytochalisin D disrupts
nuclear translocation of F-actin, promoter-targeted
siRNA and Ago1 and 2
To conﬁrm our ﬁndings of cytoskeleton involvement in
nuclear transport of promoter-targeted siRNA, we pre-
treated mock-, SIV- or HIVSF162 infected cells with the
actin depolymerising agent, cytochalisin D (cytD). The
fungal toxin cytD inhibits actin polymerization by binding
to the polymeric actin plus end and prevents addition of
monomeric actin (24). Following cytD treatment, we trans-
fected FLAG-tagged Ago1 and our panel of ﬂuorophore-
labeled siRNAs, and then immunoﬂuorescently stained
the cytoskeleton actin ﬁlaments with phalloidin-AF647
24h later. Analysis by confocal laser scanning micros-
copy revealed that treatment with cytD disrupted
nuclear trafﬁcking, with no nuclear localization observed
for F-actin or siRNAs in any cytD treated SIV- or
HIV-1SF162 infected cultures. As shown in our previ-
ous experiment, cytD untreated SIV- (Supplementary
Figure S6A) and HIV-1SF162 (Figure 9A) infected cells
co-transfected with Ago1 and si2A-AF555 or siPromA-
AF555, respectively, were associated with F-actin and
promoter-targeted siRNA redistribution to the nuclear
compartment. In stark contrast, when we pretreated
SIV- (Supplementary Figure S6B) and HIV-1SF162
(Figure 9B) infected cells with cytD, followed by co-
transfection with Ago1 and si2A-AF555 or siPromA-
AF555, respectively, we observed disordered, punctate
F-actin in the cytoplasm with less peripheral staining
and cytoplasmic siRNA staining. Mock-, SIV- and
HIV-1SF162 infected cells not treated with cytD and
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AF555 or siPromA-M2-AF555 all showed normal cyto-
plasmic F-actin distribution and predominantly cytoplas-
mic siRNA localization. Similarly, mock-, SIV- and
HIV-1SF162 infected cells that were treated with cytD,
then co-transfected with Ago1 and scrambled siRNAs
(Figure 9C and Supplementary Figure S6C),
siGag-AF555 or siPromA-M2-AF555 also showed cyto-
plasmic siRNA localization, along with disordered and
punctate cytoplasmic F-actin, with less cell periphery
Figure 8. Immunoﬂuorescent analysis of Ago1 and F-actin in HIV-1-infected HeLa cells. (A) Mock-infected cells co-transfected with Ago1 and
unlabeled siPromA. (B) HIV-infected cells co-transfected with Ago1 and siPromA. (C) HIV-infected cells co-transfected with Ago1 and scrambled
siRNA. Ago1 labeled with AF555 shows red ﬂuorescence, F-actin is labeled with phalloidin-AF647 (pseudocolored magenta), Lamin B labeled with
AF488 (green ﬂuorescence) indicates nuclear envelope and DAPI nuclear stain is pseudocolored blue. Arrows indicate nuclear localization in
HIV-infected cells. Magniﬁcation 63 , bars represent 5mm. Images are representative of three experiments. (D) Pearson’s correlation coefﬁcient
values are shown for Ago1 and DAPI (upper left panel), F-actin and DAPI (upper middle panel), Ago1 and F-actin (upper right panel), Ago1 and
LaminB (lower left panel) and F-actin and LaminB (lower right panel). NS, not signiﬁcant. *P=0.02, **P=0.002. (E) IP analysis of HIV-1 infected
cells transfected with FLAG-tagged Ago1 or empty vector and siPromA. Cytoplasmic and nuclear fractions applied to IP are shown in the left panel
(input) and proteins that immunoprecipitated with the FLAG-M2 agarose afﬁnity gel are shown in the right panel (IP samples). Samples were
probed by western blot with antibodies to b-actin (upper panel), Ago (middle panel) or FLAG-M2 (lower panel). WB, western blot; Frac, fraction;
C, cytoplasmic; N, nuclear; Ctrl-FLAG, control empty vector.
1590 Nucleic Acids Research, 2012,Vol.40, No. 4staining due to depolymerization by cytD. Importantly,
image analysis showed no signiﬁcant nuclear localization
of F-actin or siRNAs in any of the cytD treated SIV-
(Supplementary Figure S6D) or HIV-1SF162 (Figure 9D)
infected cultures. An interesting ﬁnding we only
observed in cytD cultures was a signiﬁcant level of cyto-
plasmic co-localization between F-actin and si2A-AF555
or siPromA-AF555 in SIV- and HIV-1SF162 infected
cells, respectively (0.19±0.02 and 0.17±0.02, respect-
ively), compared to mock-infected cells (0.08±0.01
and 0.09±0.01, respectively) (both P=0.01) and all
other cultures (Figure 9D, Supplementary Figure
S6D). This indicates F-actin and promoter-targeted
siRNAs have the ability to be spatially related as
shown by co-localization in the cytoplasm. We
observed slightly higher PCC values quantifying
co-localization between F-actin and the nuclear
envelope in all cytD treated mock-, SIV- and
HIV-1SF162 cultures compared to untreated cultures;
however, this was an effect of F-actin depolymerization
and was not signiﬁcant when compared amongst all
cytD-treated cultures.
We then investigated the effect of cytD treatment on the
localization of F-actin and Ago1 and 2 using the same
HIV-1 experimental model as above, but with unlabeled
siRNA so we could stain FLAG-tagged constructs with
AF555 secondary antibody and maintain our 4-color
confocal staining panel. We observed consistent cytoplas-
mic staining of Ago1 and 2 and disordered, punctate
F-actin staining in the cytoplasm of all cultures treated
with cytD and transfected with siPromA, speciﬁcity con-
trols or empty vector (Supplementary Figure S7A–D).
Further, there were no signiﬁcant correlations observed
for any ﬂuorescently stained markers (Ago1 and 2,
F-actin, DAPI and LaminB) (Supplementary Figure S7E
and F). Together these ﬁndings suggest polymeric actin
ﬁlaments are involved in delivering promoter-targeted
siRNAs and Ago1 and 2 to the nuclear compartment
during TGS of retroviruses.
DISCUSSION
We investigated the mechanisms of siRNA-induced TGS
during retrovirus infection by direct visualization of
Figure 9. Immunoﬂuorescent analysis of HIV-1 promoter-targeted siRNA and F-actin in cytochalisin D-treated HeLa cells. (A) HIV-1SF162 infected
cells co-transfected with Ago1 and siPromA, not treated with cytochalisin D (CytD). (B) HIV-1SF162 infected cells co-transfected with Ago1 and
siPromA, not treated with CytD. (C) HIV-1SF162 infected cells pre-treated with cytochalisinD and co-transfected with Ago1 and siPromA. siRNAs
labeled with AF555 show red ﬂuorescence, F-actin is labeled with phalloidin-AF647 (pseudocolored magenta), Lamin B labeled with AF488 (green
ﬂuorescence) indicates nuclear envelope and DAPI nuclear stain is pseudocolored blue. Arrows indicate nuclear localized F-actin staining in panel b
and punctate cytoplasmic F-actin staining in (C). Magniﬁcation 63 , bars represent 5mm. Images are representative of three experiments. (D)
Pearson’s correlation coefﬁcient values for CytD treated cultures are shown for siRNA and DAPI (left panel), F-actin and DAPI (middle panel) and
siRNA and F-actin (right panel). NS, not signiﬁcant; *P=0.01.
Nucleic Acids Research,2012, Vol.40, No. 4 1591critical components of RITS-like complex. We describe
both distinct subcellular distribution of RITS-like
complex components and a novel nuclear transport mech-
anism for RITS-like components mediated by the actin
ﬁlament (F-actin) component of the cytoskeleton. Ago1
and promoter-targeted siRNAs were found preferentially
in the nucleus of retrovirus-infected cells, while Ago2 and
promoter-targeted siRNAs were found in the inner
nuclear envelope of retrovirus-infected cells. The distinct
nuclear compartmentalization of these RITS-like compo-
nents was observed only in infected cultures, suggesting
accumulation of RITS-like components in the nucleus of
infected cells during TGS. The clear association between
Ago1 and promoter-targeted siRNAs in the nucleus is
consistent with the site of TGS being nuclear and
supports previous studies suggesting Ago1 and siRNAs
are RITS-like complex components (2,4). Our interesting
ﬁnding that Ago2 co-localized with promoter-targeted
siRNAs in the inner nuclear lamin membrane indicated
the association alone between Ago2 and promoter-
targeted siRNAs was not sufﬁcient for nuclear transport.
This may be due to Ago2 possibly requiring Ago1 for
nuclear trafﬁcking as part of the RITS-like complex.
Our experiments, which separately expressed exogenous
FLAG-tagged Ago1 or Ago2, but not both combined,
may indicate the low endogenous levels of Ago1 are not
adequate to facilitate nuclear transport of exogenous
FLAG-tagged Ago2 protein. It is tempting to speculate
that Ago2 could also be retained in the nuclear pore
complex (NPC), further regulating trafﬁc of protein com-
plexes between the nucleus and cytoplasm (25); however,
additional co-localization studies are required for
conﬁrmation.
This study demonstrated the distinct distribution of
Ago:siRNAs using two different retroviruses;
SIVmac251 and two different HIV-1 subtype B strains:
CXCR4-tropic HIV-1SF162 and CCR5-tropic HIV-1LAV.
Observing the same phenomenon in all three retrovirus
infection TGS models highlights that the ﬁndings are
compelling. Moreover, it is important to appreciate that
the si2A sequence, targeting a region well upstream of the
SIV NF-kB binding motif, is quite different from the
siPromA sequence, targeting the tandem NF-kB binding
motifs in the HIV-1 5‘ LTR promoter region. To provide
important speciﬁcity controls for our experiments, we
showed that scrambled siRNAs and siPromA-M2, which
varies from HIV-1 promoter-targeted siPromA by only
two bp, had no effect on nuclear co-localization of
RITS-like components and were instead found in the cyto-
plasm. We also conﬁrmed the previously reported ﬁnding
that the antisense siRNA strand participates in the forma-
tion of the RITS-like complex in human cells (26,27), as
shown by our experiments using two different HIV-1
subtype B strains, where only the antisense strand of
siPromA was labeled.
The distinct subcellular compartmentalization of
Ago:siRNA led us to investigate the mechanism regulating
nuclear transport of these RITS-like components. Studies
in S. pombe have found RNAi machinery proteins and
RNAi-associated P bodies are transported via cytoskel-
eton microtubule networks in the cytoplasm (28–30). A
recent report further describes the microtubule-associated
kinesin motor protein Cut7 regulates cytoplasmic RNAi
effector complexes during PTGS, but not TGS (31). Our
study focused on elucidating mechanisms of the TGS
pathway and reports the novel ﬁnding of cytoskeleton
polymeric actin being linked to transport of promoter-
targeted siRNAs as part of RNAi machinery in the
nucleus of mammalian cells. Although both promoter-
targeted siRNAs and F-actin were found to localize to
the nucleus of retrovirus-infected cells, there was no sig-
niﬁcant co-localization of these two molecules within the
nucleus as quantiﬁed by PCC values. This indicates that
while F-actin may play a role in nuclear trafﬁcking of
promoter-targeted siRNAs, it may not necessarily directly
interact with siRNA:Ago1 in the nucleus during transcrip-
tional suppression, although Ago1 was observed to
directly associated with b-actin by immunoprecipiation.
Furthermore, when we depolymerized actin using cytD
treatment, we did ﬁnd signiﬁcant co-localization between
F-actin and promoter-targeted siRNAs in the cytoplasm,
demonstrating that they are spatially related in this com-
partment and could interact. Alternately, Abps are known
to be involved in nucleocytoplasmic transport and may
provide the bridging link between the long ﬁlamentous
F-actin structure and promoter-targeted siRNAs. This
may also account for the biochemical association
observed between F-actin and Ago1, although the effect
could also be a direct protein interaction but ﬁne delinea-
tion of this requires further investigation. Abps proteins
associate with actin to continuously regulate actin poly-
merization, cross-link actin ﬁlaments and move cargo
along the ﬁlaments. The TGS pathway may utilize this
association to load RITS-like complex components onto
actin ﬁlaments in the cytoplasm, trafﬁc them into the
nuclear compartment, then disassociate from the actin
ﬁlament once in the nucleus.
Coﬁlin, is one such Abp essential for chaperoning actin
into the nucleus, as shown by an associated block in
nuclear actin accumulation upon inhibiting coﬁlin (32).
Another Abp of interest is the giant NUANCE
(NUcleus and ActiN Connecting Element) protein, also
termed Nesprin-2 Giant (33). This mammalian nesprin
protein has an N-terminal region comprising of an
a-actinin-type actin-binding domain, which facilitates the
physical connection between the nucleus and actin cyto-
skeleton. Nesprins also interact with emerin in the inner
nuclear membrane (34), where emerins have been shown
to bind F-actin (35). Interestingly, Arps have also been
found in the nucleus and physically interact with
chromatin-modifying complexes, speciﬁcally Arp4 and 6,
which co-localize with heterchromatin protein 1 (HP1) in
Drosophila (36,37). The Arp BAF53 also associates with
actin as part of the BAF chromatin-modifying complex in
humans (38). Many proteins have also been identiﬁed to
associate with Ago1 and Ago2 as part of the RNAi ma-
chinery. These include TBRC6B, MOV10, nuclear DNA
helicase II (also termed RNA helicase A), Importin 8,
Gemin3, Gemin4, HDAC-1 and EZH2 (1,5,39,40).
Furthermore, nuclear DNA helicase II has been shown
to bind F-actin in the nucleus of human cells (41). All of
these proteins are further candidates worthy of
1592 Nucleic Acids Research, 2012,Vol.40, No. 4investigation using our model to dissect the mechanisms of
mammalian TGS.
Nuclear actin and myosin are also reported to regulate
nucleo-cytoplasmic transport, possibly as NPC compo-
nents (42). This nucleo-cytoplasmic transport is an ATP-
dependent process and is inhibited by cytD treatment (42),
suggesting that our observations of siRNA nuclear import
inhibition during cytD treatment also indicates nuclear
import of RITS-like components is an ATP-dependent
process. Nuclear import of some Ago proteins also
requires association with siRNAs, as demonstrated for
the C. elegans Ago protein NRDE-3 (43). Moreover, in
mice the Ago protein MIWI2 binds Piwi-associated (pi)
RNAs and is localized to the nucleus (44). Another study
shows the protozoan Tetrahymena Ago protein Twi1p
associated with siRNA is transported into the nucleus
via Giw1p (45). These studies suggest a mechanism that
selectively transports only Ago proteins that are asso-
ciated with siRNAs. Our ﬁndings support this selection
mechanism, which would explain why we only observed
co-localized FLAG-tagged Ago and siRNA in the nucleus
of retrovirus-infected cells and not Ago or siRNA alone.
Our study shows a distinct subcellular distribution of
Ago proteins and promoter-targeted siRNAs in the nu-
clear compartment of retrovirus-infected cells and directly
links the actin cytoskeleton with nuclear delivery. We
propose a model for the nuclear import of RITS-like com-
ponents whereby F-actin translocation into the nuclear
compartment, primarily the inner nuclear membrane, cor-
responds to nuclear delivery of promoter-targeted
siRNAs, which then recruit other proteins to form the
nuclear RITS-like complex (Figure 10). Although we
have shown both co-localization and a direct biochemical
interaction between F-actin and FLAG-tagged Ago1
protein in the nucleus of retrovirus-infected cells, it is im-
portant to understand that other factors may also interact
with actin ﬁlaments in the cytoplasm to facilitate the
mechanical delivery of promoter-targeted siRNAs and
Ago proteins into the nuclear compartment. It is likely
that other factors also contribute to nuclear transport
and regulation of this process during TGS warrants
further investigation. The ﬁndings of our study present dir-
ect visualization of siRNA, Ago1 and Ago2 in the mam-
malian TGS pathway. The study also provides valuable
insight into the fundamental mechanism underlying
nuclear trafﬁcking of RITS-like complex components by
the actin cytoskeleton, which may also be functional in
lower eukaryotes.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Figures S1–S7.
ACKNOWLEDGEMENTS
SIVmac251 was obtained from National Institutes of
Health AIDS Research (cat. nos. 160), Shinichi Oka and
Masashi Tastumi (National Institute of Infectious
Diseases and AIDS Clinical Center, International
Medical Center of Japan, Tokyo, Japan) kindly
provided the MAGIC-5 cells. We thank Tri Phan
(Garvan Institute) for helpful discussions of our initial
confocal microscopy experiments. The views expressed in
this publication do not necessarily represent the position
of the Australian Government. The Kirby Institute is
afﬁliated with the Faculty of Medicine, University of
New South Wales.
FUNDING
Australian Government Department of Health and
Ageing (RM07292); National Health and Medical
Research Council (455350 to A.K., 630571 for K.S. and
Figure 10. Model of the actin cytoskeleton role in nuclear trafﬁcking of mammalian RITS-like complex components. Our results show that Ago1
and promoter-targeted siRNA co-localize in the nucleus of retrovirus-infected cells as part of the RITS-like complex during TGS, while Ago2 and
promoter-targeted siRNAs co-localize in the inner nuclear envelope membrane (inner NM) of retrovirus-infected cells during TGS. Our ﬁndings
suggest that nuclear delivery of RITS-like complex components, speciﬁcally promoter-targeted siRNAs associated with Ago1, involves the cytoskel-
eton actin ﬁlament (F-actin), probably via active transport through the nuclear pore complex (NPC). In response to F-actin translocating into the
nucleus, we speculate that monomeric actin (G-actin) levels would increase in the cytoplasm. Shown on the left is a cell actively undergoing
transcription, prior to transfected siRNAs associating with Ago protein/s. On the right is a cell undergoing TGS, where the siRNAs have associated
with Ago protein/s and are trafﬁcked into the nucleus with the involvement of the actin cytoskeleton.
Nucleic Acids Research,2012, Vol.40, No. 4 1593C.H.). Funding for open access charge: St Vincent’s
Centre for Applied Medical Research.
Conﬂict of interest statement. None declared.
REFERENCES
1. Kim,D.H., Villeneuve,L.M., Morris,K.V. and Rossi,J.J. (2006)
Argonaute-1 directs siRNA-mediated transcriptional gene silencing
in human cells. Nat. Struct. Mol. Biol., 13, 793–797.
2. Morris,K.V., Chan,S.W., Jacobsen,S.E. and Looney,D.J. (2004)
Small interfering RNA-induced transcriptional gene silencing in
human cells. Science, 305, 1289–1292.
3. Robb,G.B., Brown,K.M., Khurana,J. and Rana,T.M. (2005)
Speciﬁc and potent RNAi in the nucleus of human cells. Nat.
Struct. Mol. Biol., 12, 133–137.
4. Lim,H.G., Suzuki,K., Cooper,D.A. and Kelleher,A.D. (2008)
Promoter-targeted siRNAs induce gene silencing of simian
immunodeﬁciency virus (SIV) infection in vitro. Mol. Ther., 16,
565–570.
5. Suzuki,K., Juelich,T., Lim,H., Ishida,T., Watanebe,T.,
Cooper,D.A., Rao,S. and Kelleher,A.D. (2008) Closed chromatin
architecture is induced by an RNA duplex targeting the HIV-1
promoter region. J. Biol. Chem., 283, 23353–23363.
6. Suzuki,K., Shijuuku,T., Fukamachi,T., Zaunders,J., Guillemin,G.,
Cooper,D. and Kelleher,A. (2005) Prolonged transcriptional
silencing and CpG methylation induced by siRNAs targeted to
the HIV-1 promoter region. J. RNAi Gene Silencing, 1, 66–78.
7. Yamagishi,M., Ishida,T., Miyake,A., Cooper,D.A., Kelleher,A.D.,
Suzuki,K. and Watanabe,T. (2009) Retroviral delivery of
promoter-targeted shRNA induces long-term silencing of HIV-1
transcription. Microbes. Infect., 11, 500–508.
8. Pollard,T.D. and Cooper,J.A. (2009) Actin, a central player in
cell shape and movement. Science, 326, 1208–1212.
9. Hofmann,W.A., Stojiljkovic,L., Fuchsova,B., Vargas,G.M.,
Mavrommatis,E., Philimonenko,V., Kysela,K., Goodrich,J.A.,
Lessard,J.L., Hope,T.J. et al. (2004) Actin is part of pre-initiation
complexes and is necessary for transcription by RNA polymerase
II. Nat. Cell. Biol., 6, 1094–1101.
10. Ishida,T.K., Tojo,T., Aoki,T., Kobayashi,N., Ohishi,T.,
Watanabe,T., Yamamoto,T. and Inoue,J. (1996) TRAF5, a novel
tumor necrosis factor receptor-associated factor family protein,
mediates CD40 signaling. Proc. Natl Acad. Sci. USA, 93,
9437–9442.
11. Berg,J., Doe,B., Steimer,K.S. and Wabl,M. (1991) HeLa-LAV, an
epithelial cell line stably infected with HIV-1. J. Virol. Methods,
34, 173–180.
12. Abramoff,M.D., Magelhaes,P.J. and Ram,S.J. (2004) Image
Processing with ImageJ. Biophoton. Int., 11, 36–42.
13. Zinchik,V., Zinchuk,O. and Okada,T. (2007) Qualitative
colocalization analysis of multicolor confocal immunoﬂuoresence
microscopy images: pushing pixels to explore biological
phenomena. Acta Histochem. Cytochem., 40, 101–111.
14. Suzuki,K., Craddock,B.P., Okamoto,N., Kano,T. and
Steigbigel,R.T. (1993) Poly A-linked colorimetric microtiter plate
assay for HIV reverse transcriptase. J. Virol. Methods, 44,
189–198.
15. Babakov,V.N., Petukhova,O.A., Turoverova,L.V.,
Kropacheva,I.V., Tentler,D.G., Bolshakova,A.V., Podolskaya,E.P.,
Magnusson,K.E. and Pinaev,G.P. (2008) RelA/NF-kappaB
transcription factor associates with alpha-actinin-4.
Exp. Cell Res., 314, 1030–1038.
16. Kazuo Suzuki,T.I., Yamagishi,M., Ahlenstiel,C., Swaminathan,S.,
Marks,K., Murray,D., McCartney,E.M., Beard,M.R.,
Alexander,M., Purcell,D.F.J. et al. (2011) Transcriptional gene
silencing of HIV-1 through promoter targeted RNA is highly
speciﬁc. RNA Biol., November 1 (epub ahead of print).
17. Jinek,M. and Doudna,J.A. (2009) A three-dimensional view of the
molecular machinery of RNA interference. Nature, 457, 405–412.
18. Jakymiw,A., Lian,S., Eystathioy,T., Li,S., Satoh,M., Hamel,J.C.,
Fritzler,M.J. and Chan,E.K. (2005) Disruption of GW bodies
impairs mammalian RNA interference. Nat. Cell. Biol., 7,
1267–1274.
19. Janowski,B.A., Huffman,K.E., Schwartz,J.C., Ram,R.,
Nordsell,R., Shames,D.S., Minna,J.D. and Corey,D.R. (2006)
Involvement of AGO1 and AGO2 in mammalian transcriptional
silencing. Nat. Struct. Mol. Biol., 13, 787–792.
20. Liu,J., Carmell,M.A., Rivas,F.V., Marsden,C.G., Thomson,J.M.,
Song,J.J., Hammond,S.M., Joshua-Tor,L. and Hannon,G.J. (2004)
Argonaute2 is the catalytic engine of mammalian RNAi. Science,
305, 1437–1441.
21. Meister,G., Landthaler,M., Patkaniowska,A., Dorsett,Y., Teng,G.
and Tuschl,T. (2004) Human Argonaute2 mediates RNA cleavage
targeted by miRNAs and siRNAs. Mol. Cell, 15, 185–197.
22. Cameron,P.U., Saleh,S., Sallmann,G., Solomon,A., Wightman,F.,
Evans,V.A., Boucher,G., Haddad,E.K., Sekaly,R.P., Harman,A.N.
et al. (2010) Establishment of HIV-1 latency in resting CD4+ T
cells depends on chemokine-induced changes in the actin
cytoskeleton. Proc. Natl Acad. Sci. USA, 107, 16934–16939.
23. Wulf,E., Deboben,A., Bautz,F.A., Faulstich,H. and Wieland,T.
(1979) Fluorescent phallotoxin, a tool for the visualization of
cellular actin. Proc. Natl Acad. Sci. USA, 76, 4498–4502.
24. Sampath,P. and Pollard,T.D. (1991) Effects of cytochalasin,
phalloidin, and pH on the elongation of actin ﬁlaments.
Biochemistry, 30, 1973–1980.
25. Makhnevych,T., Lusk,C.P., Anderson,A.M., Aitchison,J.D. and
Wozniak,R.W. (2003) Cell cycle regulated transport controlled by
alterations in the nuclear pore complex. Cell, 115, 813–823.
26. Weinberg,M.S., Villeneuve,L.M., Ehsani,A., Amarzguioui,M.,
Aagaard,L., Chen,Z.X., Riggs,A.D., Rossi,J.J. and Morris,K.V.
(2006) The antisense strand of small interfering RNAs directs
histone methylation and transcriptional gene silencing in human
cells. RNA, 12, 256–262.
27. Schwartz,J.C., Younger,S.T., Nguyen,N.B., Hardy,D.B.,
Monia,B.P., Corey,D.R. and Janowski,B.A. (2008) Antisense
transcripts are targets for activating small RNAs. Nat. Struct.
Mol. Biol., 15, 842–848.
28. Aizer,A., Brody,Y., Ler,L.W., Sonenberg,N., Singer,R.H. and
Shav-Tal,Y. (2008) The dynamics of mammalian P body
transport, assembly, and disassembly in vivo. Mol. Biol. Cell, 19,
4154–4166.
29. Carmichael,J.B., Stoica,C., Parker,H., McCaffery,J.M.,
Simmonds,A.J. and Hobman,T.C. (2006) RNA interference
effector proteins localize to mobile cytoplasmic puncta in
Schizosaccharomyces pombe. Trafﬁc, 7, 1032–1044.
30. Sweet,T.J., Boyer,B., Hu,W., Baker,K.E. and Coller,J. (2007)
Microtubule disruption stimulates P-body formation. RNA, 13,
493–502.
31. Stoica,C., Park,J., Pare,J.M., Willows,S. and Hobman,T.C. (2010)
The Kinesin motor protein Cut7 regulates biogenesis and function
of Ago1-complexes. Trafﬁc, 11, 25–36.
32. Pendleton,A., Pope,B., Weeds,A. and Koffer,A. (2003)
Latrunculin B or ATP depletion induces coﬁlin-dependent
translocation of actin into nuclei of mast cells. J. Biol. Chem.,
278, 14394–14400.
33. Zhen,Y.Y., Libotte,T., Munck,M., Noegel,A.A. and
Korenbaum,E. (2002) NUANCE, a giant protein connecting the
nucleus and actin cytoskeleton. J. Cell. Sci., 115, 3207–3222.
34. Zhang,Q., Ragnauth,C.D., Skepper,J.N., Worth,N.F.,
Warren,D.T., Roberts,R.G., Weissberg,P.L., Ellis,J.A. and
Shanahan,C.M. (2005) Nesprin-2 is a multi-isomeric protein that
binds lamin and emerin at the nuclear envelope and forms a
subcellular network in skeletal muscle. J. Cell. Sci., 118, 673–687.
35. Holaska,J.M., Kowalski,A.K. and Wilson,K.L. (2004) Emerin
caps the pointed end of actin ﬁlaments: evidence for an actin
cortical network at the nuclear inner membrane. PLoS Biol., 2,
E231.
36. Kato,M., Sasaki,M., Mizuno,S. and Harata,M. (2001) Novel
actin-related proteins in vertebrates: similarities of structure and
expression pattern to Arp6 localized on Drosophila
heterochromatin. Gene, 268, 133–140.
37. Ohfuchi,E., Kato,M., Sasaki,M., Sugimoto,K., Oma,Y. and
Harata,M. (2006) Vertebrate Arp6, a novel nuclear actin-related
protein, interacts with heterochromatin protein 1.
Eur. J. Cell Biol., 85, 411–421.
1594 Nucleic Acids Research, 2012,Vol.40, No. 438. Zhao,K., Wang,W., Rando,O.J., Xue,Y., Swiderek,K., Kuo,A.
and Crabtree,G.R. (1998) Rapid and phosphoinositol-dependent
binding of the SWI/SNF-like BAF complex to chromatin after T
lymphocyte receptor signaling. Cell, 95, 625–636.
39. Hock,J., Weinmann,L., Ender,C., Rudel,S., Kremmer,E.,
Raabe,M., Urlaub,H. and Meister,G. (2007) Proteomic and
functional analysis of Argonaute-containing mRNA-protein
complexes in human cells. EMBO Rep., 8, 1052–1060.
40. Weinmann,L., Hock,J., Ivacevic,T., Ohrt,T., Mutze,J., Schwille,P.,
Kremmer,E., Benes,V., Urlaub,H. and Meister,G. (2009) Importin
8 is a gene silencing factor that targets argonaute proteins to
distinct mRNAs. Cell, 136, 496–507.
41. Zhang,S., Kohler,C., Hemmerich,P. and Grosse,F. (2004) Nuclear
DNA helicase II (RNA helicase A) binds to an F-actin
containing shell that surrounds the nucleolus. Exp. Cell Res., 293,
248–258.
42. Schindler,M. and Jiang,L.W. (1986) Nuclear actin and myosin as
control elements in nucleocytoplasmic transport. J. Cell Biol.,
102, 859–862.
43. Guang,S., Bochner,A.F., Pavelec,D.M., Burkhart,K.B.,
Harding,S., Lachowiec,J. and Kennedy,S. (2008) An Argonaute
transports siRNAs from the cytoplasm to the nucleus. Science,
321, 537–541.
44. Aravin,A.A., Sachidanandam,R., Bourc’his,D., Schaefer,C.,
Pezic,D., Toth,K.F., Bestor,T. and Hannon,G.J. (2008) A piRNA
pathway primed by individual transposons is linked to de novo
DNA methylation in mice. Mol. Cell, 31, 785–799.
45. Noto,T., Kurth,H.M., Kataoka,K., Aronica,L., DeSouza,L.V.,
Siu,K.W., Pearlman,R.E., Gorovsky,M.A. and Mochizuki,K.
(2010) The Tetrahymena argonaute-binding protein Giw1p directs
a mature argonaute-siRNA complex to the nucleus. Cell, 140,
692–703.
Nucleic Acids Research,2012, Vol.40, No. 4 1595